2000
DOI: 10.1021/cr990297n
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Complex Carbohydrates and Glycoconjugates:  Enzyme-Based and Programmable One-Pot Strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
243
0
6

Year Published

2002
2002
2016
2016

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 466 publications
(251 citation statements)
references
References 368 publications
1
243
0
6
Order By: Relevance
“…Antibodies (their size is about 12 nm) endowed with fluorescent dyes (e.g., Alexa Fluor 488 λEm=525 nm and Texas Red λEm=609 nm) [15][16][17] were used in the development of a wide range of effective targeted therapies [18][19][20][21][22] but they create clustering artifacts due to limited antibody penetration, which have an impact on insufficient labeling density. Thus, ligands that have been exploited for chemotherapeutic agent targeting systems can include monoclonal antibodies [23][24][25][26][27][28] but also low molecular weight receptor-binding conjugates such as dyelabeled peptides (arginine-glycine-aspartic acid-Cyt5,5) [29], peptide hormones [30,31], receptor antagonist and agonists [32], aptamers [33][34][35], transferrin [36][37], oligosaccharides [38], glycoconiugates [39], polyunsaturated fatty acids [40], oligopeptides [41,42], vitamin B12 [43], folic acid [44][45][46][47][48][49][50][51][52][53][54] and hyaluronic acid [55,56]. These ligands can be regarded as a tumor-specific receptor to construct a "guided molecular ...…”
Section: Fluorescent Small Molecules As Cell-type-specific Imaging Prmentioning
confidence: 99%
“…Antibodies (their size is about 12 nm) endowed with fluorescent dyes (e.g., Alexa Fluor 488 λEm=525 nm and Texas Red λEm=609 nm) [15][16][17] were used in the development of a wide range of effective targeted therapies [18][19][20][21][22] but they create clustering artifacts due to limited antibody penetration, which have an impact on insufficient labeling density. Thus, ligands that have been exploited for chemotherapeutic agent targeting systems can include monoclonal antibodies [23][24][25][26][27][28] but also low molecular weight receptor-binding conjugates such as dyelabeled peptides (arginine-glycine-aspartic acid-Cyt5,5) [29], peptide hormones [30,31], receptor antagonist and agonists [32], aptamers [33][34][35], transferrin [36][37], oligosaccharides [38], glycoconiugates [39], polyunsaturated fatty acids [40], oligopeptides [41,42], vitamin B12 [43], folic acid [44][45][46][47][48][49][50][51][52][53][54] and hyaluronic acid [55,56]. These ligands can be regarded as a tumor-specific receptor to construct a "guided molecular ...…”
Section: Fluorescent Small Molecules As Cell-type-specific Imaging Prmentioning
confidence: 99%
“…Foi relatada a ocorrência de derivados dos ácidos siálicos 1, 2 e 3 que incorporam em suas estruturas um ou mais grupos acetilas, ou envolvem a lactonização ou fosforilação da hidroxila em C9 ou a metilação ou sulfatação da hidroxila em C8. Como componentes de glicoconjugados, os ácidos siálicos são encontrados ligados a hexoses, como α(2,3)-ou α(2,6)-β-Gal ou β-GalNHR e ligados a outros áci-dos siálicos como α(2,8) 11,13 .…”
Section: (Figura 3) a N-acetil-d-unclassified
“…Not only are they ubiquitous natural products occurring throughout the biosphere, but also they provide key functional sub-units for rational drug designs [17]. They are inexpensive yet powerful members of the chiral pool, which makes them attractive platforms for asymmetric synthesis [18]. We recently reported a new method for the generation of aryldiazomethanes from stable tosylhydrazone derivatives.…”
Section: Introductionmentioning
confidence: 99%